Provention Bio, Inc.

Profitability for 1 year: 0%
Dividend yield: 0%
Sector: Healthcare

Provention Bio, Inc.

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
0/10
-20.25 36.09 -156.09% -8.78 +130.53%
P/S 56.73 127.4 -55.47%
P/BV 6 254.48 -97.64%
P/FCF -30.18 -175.09 -82.76%
Ev/Ebitda -5.71 -27.32 -79.12%
Ev/S 55.15 535.99 -89.71%
Ev/FCF -9.34 -282.69 -96.7%
E/P -0.0494 0.022 -324.91%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
0/10
-966.67 -366.96 163.43% -2430.8 -60.23%
ROE 133.43 104.24 28%
ROA -60.98 -2.25 2607.37%
ROIC -74.56 1.17 -6451.25%
ROS -880.62 -291.95 201.64%
ROCE -105.17 3.12 -3474.2%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
-0.19 0.98 -119.58% -0.19 -0.0097%
Nеt Debt/Ebitda 0.16 1.06 -84.74%
Debt/Ratio 0.1 0.18 -43.85%
Debt/Equity 0.94 1.59 -40.7%
Debt/Net Income -0.21 -1.45 -85.51%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 0.53 -100% 0 0%
Number of years of dividend growth 0 0.8 -100%
DSI 0 0.22 -100%
Average dividend growth 0 2.43 -100%
Average percentage for 5 years 0 0.49 -100%
Average percentage for payments 0 59.01 -100%
Difference from average difference in sector -0.53

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
10/10
821.43 -73.42 -1218.81%
Growth impulse Ebitda in 5 years 181.31 -97.71 -285.56%
Growth impulse Net Income in 5 years 167.77 -85.91 -295.29%
Growth impulse FCF in 5 years 111.08 -91.82 -220.98%
Growth impulse EPS in 5 years 45.19 -75.92 -159.52%
IP Score
4.56/10

Similar companies

Alexion

ABIOMED

Gilead Sciences

Amgen

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription